497.75
-4.95
(-0.98%)
At close: April 10 at 11:19:18 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 23 | 23 | 36 | 35 |
Avg. Estimate | 4.2B | 4.38B | 18.14B | 20.93B |
Low Estimate | 4.16B | 4.27B | 17.65B | 19.94B |
High Estimate | 4.29B | 4.46B | 18.7B | 21.82B |
Year Ago Sales | 3.64B | 3.81B | 15.67B | 18.14B |
Sales Growth (year/est) | 15.57% | 15.16% | 15.71% | 15.40% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
4SPOT.TI | -- | -- | -- | -- |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Maintains | Cantor Fitzgerald: Neutral to Neutral | 4/16/2025 |
Maintains | UBS: Buy to Buy | 4/15/2025 |
Maintains | Keybanc: Overweight to Overweight | 4/9/2025 |
Maintains | JP Morgan: Overweight to Overweight | 4/8/2025 |
Maintains | UBS: Buy to Buy | 4/2/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 3/28/2025 |